Form 8-K - Current report:
SEC Accession No. 0001641172-25-012411
Filing Date
2025-05-27
Accepted
2025-05-27 09:20:19
Documents
16
Period of Report
2025-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48648
2 EX-1.1 ex1-1.htm EX-1.1 280099
3 EX-5.1 ex5-1.htm EX-5.1 15500
4 GRAPHIC ex5-1_001.jpg GRAPHIC 5506
  Complete submission text file 0001641172-25-012411.txt   626764

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20250522.xsd EX-101.SCH 3785
6 XBRL DEFINITION FILE biaf-20250522_def.xml EX-101.DEF 26626
7 XBRL LABEL FILE biaf-20250522_lab.xml EX-101.LAB 36673
8 XBRL PRESENTATION FILE biaf-20250522_pre.xml EX-101.PRE 25250
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25984775
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)